Clinical Bioanalysis
Clinical Bioanalysis is an analytical discipline that involves the quantitative and qualitative assessment of xenobiotics and their metabolites in biological matrices within clinical settings, distinguished by its application to drug development, therapeutic drug monitoring, and biomarker validation.
87
Publications
3.4K
Citations
882
Authors
257
Institutions
Publications per year
2017–2026
32
Parents
87
1–5 of 87
882
25
h-index
19
h-index
United States Food and Drug Administration, United States
20 publications · 941 citations
18
h-index
18
h-index
16
h-index
1–5 of 882
257
Bristol-Myers Squibb (United States)
New York, United States
25 h-index
99 publications
4.8K citations
United States Food and Drug Administration
Silver Spring, United States
23 h-index
152 publications
6.1K citations
GlaxoSmithKline (United States)
Philadelphia, United States
22 h-index
50 publications
2.3K citations
Health Canada
Ottawa, Canada
21 h-index
47 publications
2.1K citations
Pfizer (United States)
New York, United States
21 h-index
93 publications
4.1K citations
United States Military Academy
West Point, United States
18 h-index
39 publications
1.6K citations
Roche (Switzerland)
Basel, Switzerland
16 h-index
28 publications
1.1K citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
16 h-index
22 publications
1.1K citations
1–8 of 257
BIO · 49 publications · 2.1K citations
29
h-index
4 publications · 116 citations
4
h-index
4 publications · 133 citations
4
h-index
2 publications · 33 citations
2
h-index
2 publications · 25 citations
2
h-index
1–5